Brian Hannasch - 11 Feb 2026 Form 4 Insider Report for Neuraxis, INC (NRXS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2026, 16:04:28 UTC
Prior SEC filing
05 Jan 2026
Next SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Griffin D. Foster, Attorney-in-Fact for Brian P. Hannasch

Key filing fact

Brian Hannasch filed Form 4 for Neuraxis, INC (NRXS) on 13 Feb 2026.

Key facts

  • This page summarizes Brian Hannasch's Form 4 filing for Neuraxis, INC (NRXS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Feb 2026, 16:04.

Change

  • Previous filing in this sequence was filed on 05 Jan 2026.
  • Current net transaction value: +$382,800.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001911504 Primary reporting owner

Hannasch Brian

Relationship
10%+ Owner
Address
8815 W. STATE ROAD 46, COLUMBUS
Signature
/s/ Griffin D. Foster, Attorney-in-Fact for Brian P. Hannasch
Signature date
13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXS transaction

Common Stock

Purchase

Transaction value
$186,000
Shares
+40,000
Change %
+3.5%
Price
$4.65
Shares after
1,171,522
Date
11 Feb 2026
Ownership
Direct
Footnotes
F1
NRXS transaction

Common Stock

Purchase

Transaction value
$196,800
Shares
+40,000
Change %
+3.4%
Price
$4.92
Shares after
1,211,522
Date
12 Feb 2026
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 11, 2026 with purchase prices ranging from $4.53 to $4.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 12, 2026 with purchase prices ranging from $4.70 to $4.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .